CSIMarket Company Name, Ticker, Suppliers, else..
 
Allurion Technologies Inc   (ALUR)
 
Price: $1.5500 $0.17 12.319%
Day's High: $1.5499999523162842 Week Perf: -11.43 %
Day's Low: $ 1.38 30 Day Perf: 162.71 %
Volume (M): 941 52 Wk High: $ 9.00
Volume (M$): $ 0 52 Wk Avg: $1.56
Open: $1.38 52 Wk Low: $0.23



 Market Capitalization (Millions $) 21
 Shares Outstanding (Millions) 13
 Employees 41
 Revenues (TTM) (Millions $) 12
 Net Income (TTM) (Millions $) -42
 Cash Flow (TTM) (Millions $) -15
 Capital Exp. (TTM) (Millions $) 0

Business Description


Allurion Technologies Inc is a medical device company that specializes in developing weight loss solutions. The company has created a non-surgical, swallowable gastric balloon known as the Elipse™ Balloon, which is designed to help individuals lose weight by reducing their caloric intake and promoting early satiety.

The Elipse Balloon is ingested orally in a capsule form and then inflated within the stomach using a small tube attached to a balloon filling device. The procedure takes only a few minutes and does not require endoscopy or anesthesia.

Once in the stomach, the balloon occupies space, making the person feel fuller faster and restricting the amount of food that can be consumed. The device stays in the stomach for approximately four months, after which it is naturally expelled from the body.

Allurion Technologies aims to provide a safe and effective weight loss solution for individuals who are struggling with obesity or being overweight. Their approach offers a non-invasive alternative to surgical procedures like gastric bypass, making it a more appealing option for many patients.

The company is committed to conducting clinical studies, research, and development to improve the performance, safety, and efficacy of their gastric balloon technology. They work closely with healthcare professionals to ensure that their weight loss solutions are both effective and reliable.

Allurion Technologies has received recognition and approval from various regulatory bodies around the world for their innovative approach to weight loss. Their mission is to help people achieve sustainable weight loss and improve their quality of life.


   Company Address: 11 Huron Drive Natick 1760 MA
   Company Phone Number: 647-4000   Stock Exchange / Ticker: ALUR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        0.27% 
BSX   -2.99%    
DXCM        1.97% 
ESTA   -3.75%    
ISRG   -0.29%    
OSUR   -5.03%    
• View Complete Report
   



Business Update

Innovative Approach to Weight Loss Allurion Smart Capsule Shows Promising Results in Recent Study

Published Thu, Nov 20 2025 3:33 PM UTC

In a significant advance in the field of weight loss and metabolic health, Allurion Technologies, Inc. (NYSE: ALUR) has announced the publication of a peer-reviewed study demonstrating the effectiveness of the Allurion Smart Capsule in combination with lifestyle interventions. The research, published in the prestigious journal Obesity Surgery, adds a new dimension to the ong...
Business Update

Allurion and Minogue Medical Forge Partnership to Transform Obesity Care in Canada

Published Thu, Jul 10 2025 5:53 PM UTC

In a groundbreaking move aimed at revolutionizing obesity management in Canada, Allurion Technologies, Inc. (NYSE: ALUR) has announced a strategic distribution partnership with Minogue Medical Inc., a respected leader in bariatric and obesity care. This collaboration marks a significant step towards integrating metabolically healthy weight loss solutions into mainstream obes...
Business Update

Allurion Technologies Revamping Obesity Treatment with Dual-Action Innovation,

Published Fri, Mar 21 2025 7:29 PM UTC

Allurion Technologies: Pioneering a New Frontier in Obesity Treatment with Combined TherapiesIn the pursuit of innovative solutions to combat the global obesity crisis, Allurion Technologies, Inc. (NYSE: ALUR) is capturing attention with its promising new strategy that integrates the Allurion Balloon with low-dose GLP-1 therapy. This dynamic approach aims not only to enhanc...
Business Update

Transforming Weight Management Allurions Groundbreaking Fusion of Balloon Therapy and GLP-1 Treatment,

Published Fri, Mar 21 2025 11:36 AM UTC

Natick, Mass. Date Allurion Technologies, Inc. (NYSE: ALUR), a company at the forefront of combating obesity, recently announced promising initial results in the integration of its Allurion Program with low-dose GLP-1 therapy. This cutting-edge approach aims to not only enhance weight loss but also to preserve and optimize muscle mass while promoting adherence to GLP-1 th...
Business Update

Allurion Technologies Pioneering a New Era in Obesity Treatment with Innovative Combination Therapy

Published Tue, Feb 18 2025 4:17 PM UTC

In the ever-evolving landscape of healthcare solutions, Allurion Technologies, Inc. (NYSE: ALUR) is poised to make significant strides in the battle against obesity. Based in Natick, Massachusetts, Allurion is a forward-thinking company dedicated to tackling this global health challenge. In a bold move that underscores its commitment to innovation, Allurion recently announce...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.67
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.14
Working Capital Ratio 0.31
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -4.07 $
Revenues (TTM) 0.93 $
Cash Flow (TTM) -
Cash 0.38 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 301,390
Net Income per Employee (TTM) -1,029,976
Receivable Turnover Ratio (TTM) 2.86
Inventory Turnover Ratio (TTM) 1.88
Asset Turnover Ratio (TTM) 0.63

Profitability Ratios Current
Gross Margin (MRQ) 41.7 %
Operating Margin (MRQ) -126.6 %
Net Margin (MRQ) -206.82 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Allurion Technologies Inc's Segments
All Other Countries    40.84 % of total Revenue
Egypt    19.53 % of total Revenue
Italy    18.14 % of total Revenue
Spain    12.24 % of total Revenue
Argentina    11.81 % of total Revenue
Chile    11.76 % of total Revenue
Australia    1.04 % of total Revenue

  Allurion Technologies Inc Outlook

On April 30 2024 the Allurion Technologies Inc provided following guidance

Allurion Technologies, Inc. (Allurion or the Company) based in Natick, Massachusetts, has released preliminary unaudited results for the first quarter of 2024. The company, focused on combating obesity, anticipates revenue between $9.2 million to $9.3 ...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.